Coltrera M D, Wang J, Porter P L, Gown A M
Department of Pathology, University of Washington, Seattle 98195, USA.
Cancer Res. 1995 Jun 15;55(12):2703-8.
Breast carcinomas are known to express platelet-derived growth factor (PDGF), a known connective tissue mitogen. In order to further evaluate the potential role of PDGF in these epithelial tumors, expression of the PDGF B chain (PDGF-B) and the PDGF receptor beta subunit (PDGFR) was analyzed by immunocytochemistry and in situ hybridization in 49 benign and malignant breast tissues. PDGF-B expression was analyzed with respect to the expression of the proliferating cell nuclear antigen, as well as tumor grade, p53 overexpression, estrogen receptor, progesterone receptor, and c-erbB-2 expression. Expression of PDGF-B protein and mRNA was restricted to the breast epithelium and tumor cells except for scattered tissue macrophages. A strong correlation was found between increasing proliferating cell nuclear antigen indices and PDGF-B expression in both nonmalignant (P = 0.01) and malignant (P = 0.02) breast specimens. Decreased PDGF-B expression was found in postmenopausal atrophic breast tissue compared with normal breast tissue (P = 0.04). Within the subgroup of malignant tumors, no correlations were found between PDGF-B expression and tumor grade or p53 overexpression. In 16 of the malignant tumors evaluated for estrogen/progesterone receptor status and c-erbB-2 overexpression, no correlations with PDGF-B expression were found. Membranous PDGFR immunostaining was present within the fibroblastic cell population in all of the tissues examined but not in the nonmalignant breast epithelium. Six malignant specimens had detectable cytoplasmic expression of PDGFR. There was no correlation between this PDGFR expression and proliferating cell nuclear antigen indices, but a correlation was noted between increasing estrogen receptor expression and PDGFR cytoplasmic expression (P = 0.04). The results support a paracrine role for PDGF-B in malignant and benign breast epithelial cell proliferation.
已知乳腺癌会表达血小板衍生生长因子(PDGF),这是一种已知的结缔组织促有丝分裂原。为了进一步评估PDGF在这些上皮性肿瘤中的潜在作用,通过免疫细胞化学和原位杂交分析了49例良性和恶性乳腺组织中PDGF B链(PDGF - B)和PDGF受体β亚基(PDGFR)的表达。针对增殖细胞核抗原的表达、肿瘤分级、p53过表达、雌激素受体、孕激素受体以及c - erbB - 2表达,对PDGF - B表达进行了分析。除了散在的组织巨噬细胞外,PDGF - B蛋白和mRNA的表达局限于乳腺上皮和肿瘤细胞。在非恶性(P = 0.01)和恶性(P = 0.02)乳腺标本中,均发现增殖细胞核抗原指数增加与PDGF - B表达之间存在强相关性。与正常乳腺组织相比,绝经后萎缩性乳腺组织中PDGF - B表达降低(P = 0.04)。在恶性肿瘤亚组中,未发现PDGF - B表达与肿瘤分级或p53过表达之间存在相关性。在评估雌激素/孕激素受体状态和c - erbB - 2过表达的16例恶性肿瘤中,未发现与PDGF - B表达存在相关性。在所有检查的组织中,成纤维细胞群体内均存在膜性PDGFR免疫染色,但在非恶性乳腺上皮中未发现。6例恶性标本中有可检测到的PDGFR细胞质表达。这种PDGFR表达与增殖细胞核抗原指数之间无相关性,但雌激素受体表达增加与PDGFR细胞质表达之间存在相关性(P = 0.04)。结果支持PDGF - B在恶性和良性乳腺上皮细胞增殖中起旁分泌作用。